{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:53:00Z","timestamp":1778561580731,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.annder.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T15:32:54Z","timestamp":1528731174000},"page":"665-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Un nouveau cas d\u2019\u00e9ruption de type pityriasis rubra pilaire associ\u00e9e \u00e0 l\u2019inhibiteur de tyrosine kinase ponatinib"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6081-8785","authenticated-orcid":false,"given":"J.","family":"Krygier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Leemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"de Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gutermuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grosber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.04.009_bib0065","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaad.2010.03.015","article-title":"Sorafenib-induced eruption resembling pityriasis rubra pilaris","volume":"65","author":"Paz","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2018.04.009_bib0070","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/ced.12081","article-title":"Pityriasis rubra pilaris-like reaction induced by imatinib","volume":"38","author":"Plana","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2018.04.009_bib0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaad.2013.04.061","article-title":"Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib","volume":"69","author":"Jack","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2018.04.009_bib0080","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bjd.13692","article-title":"Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicities","volume":"173","author":"Alloo","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2018.04.009_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40800-017-0055-y","article-title":"Ichtyosiform pityriasis rubra pilaris-like eruption secondary to ponatinib therapy: case report and literature review","volume":"4","author":"Eber","year":"2017","journal-title":"Drug Saf Case Rep"},{"key":"10.1016\/j.annder.2018.04.009_bib0090","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1056\/NEJMoa1205127","article-title":"Ponatinib in refractory Philadelphia chromosome-positive leukemias","volume":"367","author":"Cortes","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2018.04.009_bib0095","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1535-7163.MCT-10-1044","article-title":"Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies","volume":"10","author":"Gozgit","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.annder.2018.04.009_bib0100","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1306494","article-title":"A phase 2\u00a0trial of ponatinib in Philadelphia chromosome\u2013positive leukemias","volume":"369","author":"Cortes","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2018.04.009_bib0105","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S1470-2045(16)00080-2","article-title":"Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3\u00a0trial","volume":"17","author":"Lipton","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annder.2018.04.009_bib0110","first-page":"59","article-title":"Lamellar ichthyosis-like eruption associated with ponatinib","volume":"25","author":"Orenay","year":"2016","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.annder.2018.04.009_bib0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000437383","article-title":"Unique cutaneous reaction to second- and third-generation tyrosine kinase inhibitors for chronic myeloid leukemia","volume":"232","author":"Patel","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2018.04.009_bib0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/jdv.14368","article-title":"Ponatinib-induced widespread ichthyosiform eruption","volume":"31","author":"Derlino","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818304423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818304423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:37Z","timestamp":1758971197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818304423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0151963818304423"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.04.009","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Un nouveau cas d\u2019\u00e9ruption de type pityriasis rubra pilaire associ\u00e9e \u00e0 l\u2019inhibiteur de tyrosine kinase ponatinib","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}